Article

Development and validation of a reversed-phase HPLC method for the simultaneous analysis of simvastatin and tocotrienols in combined dosage forms

Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA 71201, USA.
Journal of pharmaceutical and biomedical analysis (Impact Factor: 2.45). 06/2009; 49(4):950-6. DOI: 10.1016/j.jpba.2009.02.009
Source: PubMed

ABSTRACT A RP-HPLC method for the simultaneous analysis of tocotrienol isoforms (TRF) and simvastatin (SIM) in SIM-TRF nanoparticles (NPs) was developed. Analytes were monitored by UV detection at 238 and 295 nm for SIM and TRF, respectively, using a gradient methanol/water elution. Calibration curves for TRF and SIM were linear over concentration range of 20-80 microg/mL and 1-10 microg/mL with correlation coefficients 0.9990 and 0.9991, respectively. The recovery of TRF and SIM from the NPs was in the range from 97.35 to 102.19% and from 92.71 to 104.35%, respectively. This developed method was successfully employed in quantifying both drugs in NPs for future use in cancer therapy.

1 Bookmark
 · 
103 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: A simple, selective, and precise stability-indicating reversed-phase liquid chromatographic method has been developed and validated for the determination of the first Food and Drug Administration (FDA) approved fixed-dose combination for both diabetes type II and high cholesterol; sitagliptin phosphate monohydrate (SIT); and simvastatin (SIM) in the presence of acid and alkali degradation products of SIT, and the hydrolytic degradation product of SIM. The method was based on gradient elution on a reversed phase C8 column (250mmx4.6mm, 5 mu m)-Zorbax SB using a mobile phase consisting of 0.01M potassium dihydrogen orthophosphate (pH=2.6) and acetonitrile. Quantitation was achieved using UV detection at 210nm for SIT and its degradation products, while quantitation of SIM and its degradation product was achieved using UV detection at 240nm. Linearity, accuracy, and precision were found to be acceptable over the concentration ranges of 0.5-200 mu g mL -(1) and 0.5-100 mu g mL (-1) for SIT and SIM, respectively. Limits of detection and quantitation for SIT were found to be 5.65ng and 17.12ng, respectively, while for SIM were found to be 2.72ng and 8.25ng, respectively. The proposed method was successfully applied to the determination of the cited drugs in bulk and in their combined pharmaceutical preparations.
    Journal of Liquid Chromatography &amp Related Technologies 04/2014; 37(13). DOI:10.1080/10826076.2013.825849 · 0.64 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Une méthode simple, rapide et sensible par chromatographie liquide haute performance couplée au détecteur à photodiode a été développée et validée pour la détermination simultanée du butylhydroxyanisole et de la simvastatine avec ses impuretés dans les comprimés. La séparation chromatographique a été effectuée au moyen d’une colonne Phenomenex Hypersil (250, 4,6 mm, 5 μm) en employant une phase mobile composée d’un mélange d’acétonitrile et d’acétate de sodium à 12 mM, ajusté à pH 4,2, avec un débit de 1,7 mL/min. La simvastatine et ses impuretés ont été détectées à 238 nm et le butylhydroxyanisole a été détecté à 290 nm. La solution du système de conformité utilisée pour l’identification des impuretés a été préparée en interne sans utilisation de standard de référence d’impureté. La méthode a été validée selon les guidelines ICH Q2(R1) ; et les critères d’acceptation en termes d’exactitude, fidélité, linéarité, spécificité, robustesse, LD, et LQ ont été respectés. En revanche, la reproductibilité des résultats obtenus par les 22 laboratoires officiels de contrôle des médicaments au niveau de la Direction européenne a été satisfaisante. Le choix des impuretés qui ont fait l’objet de la validation était basé sur les impuretés qui ont été formées durant la stabilité à long terme et accélérée des comprimés provenant des marchés Marocain et étrangers. La méthode présentée est robuste et appliquée avec succès en contrôle qualité de routine pour le dosage du butylhydroxyanisole et la simvastatine avec ses principales impuretés dans les comprimés.
    Annales Pharmaceutiques Françaises 07/2014; DOI:10.1016/j.pharma.2014.03.002
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Analytical methods require adequate curve adjusting models to express reliability. The ordinary or weighted least squares methods (OLSM or WLSM, respectively) were used to determine the most adequate mathematical model for the analytical curve, beginning from the simplest method (linear) to quadratic. These models were evaluated with respect to normality and homoscedasticity of the residues. Analytical curves were built by injection of 1, 5, 10, 15 and 20 mL of simvastatin at 40 µg mL-1 (40, 200, 400, 600 and 800 ng) or of 10 mL of simvastatin at 4, 20, 40, 60 and 80 µg mL-1, employing high-performance liquid chromatography with photo-diode array detection (l 238 nm). The best-adjusted models were the linear and the quadratic, when observed in terms of the dataset masses and concentrations, respectively. In the considered range, WLSM was more appropriate than OLSM. The different behavior indicated the need for careful selection of the most adequate model to express the analytical curve and the need for assuring the reliability of the used method.
    Journal of the Brazilian Chemical Society 09/2013; 24(9):1469-1477. DOI:10.5935/0103-5053.20130187 · 1.25 Impact Factor